Vital Therapies +30% Premarket as Co Announces Additional Data from VTI-208 Presentation at Rostock Conference
August 31, 2015 at 08:10 AM EDT
Vital Therapies, Inc. (Nasdaq: VTL) today announced that additional data from its VTI-208 clinical trial were presented by two ...
